InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
73.86
(
-0.38%
)
Bitcoin
63,595.40
(
0.35%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

remind2

Send PM Follow Ignore
Followers 15
Posts 1647
Boards Moderated 0
Alias Born 05/15/2015

remind2

Re: None

Friday, 12/02/2016 11:26:37 AM

Friday, December 02, 2016 11:26:37 AM

Post# of 23979
BLRX: Presents important positive data @ ASH 2016. 12/03/16


Here is the pre-release of the info and it is impressive indeed.

BL-8040 is currently being used in combo in trials with the Merck already approved cancer blockbuster drug Keytruda.

In addition, the -BL-8040 platform is being used by Norvatis in its giant move into NASH liver drug sector. A multi-billion dollar sector.

So, the BLRX presentation will be closely watched this weekend with many potential additional partners looking to add the potent BL-8040 platform to their already approved drugs to improve efficacy.


BLRX: ASH 2016 news with BL-8040 update.
http://www.biolinerx.com/default.asp?pageid=16&itemid=472


Ash 2016 link:
http://www.hematology.org/Annual-Meeting/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up